On 3/10/25, Neogenomics Inc (NASDAQ: NEO) stock suffered a major decline of -10.0%, closing at $9.09. Moreover, this decline was accompanied by above average trading volume at 139% of normal. Relative to the market the […]
Marathon Digital Holdings Inc (NASDAQ: MARA) stock suffered a major decline of -16.3% on 3/10/25. The shares closed at $13.41. Moreover, above average trading volume at 131% of normal accompanied the decline. The stock has […]
Kewaunee Scientific Corp (NASDAQ: KEQU) stock suffered a major decline of -11.2% on 3/10/25. The shares closed at $45.09. Moreover, unusually high trading volume at 162% of normal accompanied the decline. The stock has been […]
Interactive Brokers Group Inc (NASDAQ: IBKR) stock suffered a major decline of -13.0% on 3/10/25. The shares closed at $167.16. Moreover, trading volume in this decline was exceptionally high at 239% of normal. The stock […]
ICU Medical Inc (NASDAQ: ICUI) has recently experienced meaningful negative changes in fundamentals: the consensus estimate for December, 2025 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2026 decreased significantly. […]
Energy Transfer LP (NYSE: ET) has recently experienced extremely important negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, the stock fell […]
Recent extremely meaningful negative changes in investment behavior have impacted Daqo New Energy Corp (NYSE: DQ): the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and its […]
Cryo-Cell International Inc (NYSEAMERICAN: CCEL) suffers from extremely meaningful negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume. Recent significant negative changes in fundamentals have impacted Cryo-Cell […]
Canterbury Park Holding Corp (NASDAQ: CPHC) has reported E.P.S. of $-0.25 for its fourth fiscal quarter (ending December 31) versus $0.28 for the same period a year ago — a decline of -189%. E.P.S. were […]
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock suffered a major decline of -10.4% on 3/10/25. The shares closed at $15.21. NORMAL trading volume accompanied the decline. Relative to the market the stock has been weak over […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research